| Computational approaches in target identification and drug discovery T Katsila, GA Spyroulias, GP Patrinos, MT Matsoukas Computational and structural biotechnology journal 14, 177-184, 2016 | 279 | 2016 |
| A European spectrum of pharmacogenomic biomarkers: implications for clinical pharmacogenomics C Mizzi, E Dalabira, J Kumuthini, N Dzimiri, I Balogh, N Başak, R Böhm, ... PloS one 11 (9), e0162866, 2016 | 101 | 2016 |
| Personalized pharmacogenomics profiling using whole-genome sequencing C Mizzi, B Peters, C Mitropoulou, K Mitropoulos, T Katsila, MR Agarwal, ... Pharmacogenomics 15 (9), 1223-1234, 2014 | 96 | 2014 |
| Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis R Anderson, A Franch, M Castell, FJ Perez-Cano, R Bräuer, D Pohlers, ... Arthritis research & therapy 12 (4), 1-15, 2010 | 81 | 2010 |
| Sensitive monogenic noninvasive prenatal diagnosis by targeted haplotyping C Vermeulen, G Geeven, E de Wit, MJAM Verstegen, RPM Jansen, ... The American Journal of Human Genetics 101 (3), 326-339, 2017 | 78 | 2017 |
| Nutrigenomics: A controversy C Pavlidis, GP Patrinos, T Katsila Applied & translational genomics 4, 50-53, 2015 | 74 | 2015 |
| Peptide and protein drugs: the study of their metabolism and catabolism by mass spectrometry T Katsila, AP Siskos, C Tamvakopoulos Mass spectrometry reviews 31 (1), 110-133, 2012 | 73 | 2012 |
| Meta-analysis of genes in commercially available nutrigenomic tests denotes lack of association with dietary intake and nutrient-related pathologies C Pavlidis, Z Lanara, A Balasopoulou, JC Nebel, T Katsila, GP Patrinos Omics: a journal of integrative biology 19 (9), 512-520, 2015 | 40 | 2015 |
| Whole genome sequencing in pharmacogenomics T Katsila, GP Patrinos Frontiers in pharmacology 6, 61, 2015 | 37 | 2015 |
| Assessment of the pharmacogenomics educational environment in Southeast Europe C Pisanu, EE Tsermpini, E Mavroidi, T Katsila, GP Patrinos, A Squassina Public health genomics 17 (5-6), 272-279, 2014 | 35 | 2014 |
| Deciphering next-generation pharmacogenomics: an information technology perspective G Potamias, K Lakiotaki, T Katsila, MTM Lee, S Topouzis, DN Cooper, ... Open Biology 4 (7), 140071, 2014 | 34 | 2014 |
| Exploring public genomics data for population pharmacogenomics K Lakiotaki, A Kanterakis, E Kartsaki, T Katsila, GP Patrinos, G Potamias PloS one 12 (8), e0182138, 2017 | 33 | 2017 |
| Exosomes: a cancer theranostics road map A Panagiotara, A Markou, ES Lianidou, GP Patrinos, T Katsila Public health genomics 20 (2), 116-125, 2017 | 33 | 2017 |
| In vivo evaluation and in vitro metabolism of leuprolide in mice—mass spectrometry‐based biomarker measurement for efficacy and toxicity ZD Sofianos, T Katsila, N Kostomitsopoulos, V Balafas, J Matsoukas, ... Journal of mass spectrometry 43 (10), 1381-1392, 2008 | 32 | 2008 |
| Integrating next-generation sequencing in the clinical pharmacogenomics workflow E Giannopoulou, T Katsila, C Mitropoulou, EE Tsermpini, GP Patrinos Frontiers in pharmacology 10, 384, 2019 | 29 | 2019 |
| Variants in TPMT, ITPA, ABCC4 and ABCB1 genes as predictors of 6-mercaptopurine induced toxicity in children with acute lymphoblastic leukemia G Milošević, N Kotur, N Krstovski, J Lazić, B Zukić, B Stanković, D Janić, ... Journal of medical biochemistry 37 (3), 320-327, 2018 | 28 | 2018 |
| Nutrigenomics 2.0: The Need for Ongoing and Independent Evaluation and Synthesis of Commercial Nutrigenomics Tests' Scientific Knowledge Base for … C Pavlidis, JC Nebel, T Katsila, GP Patrinos Omics: A journal of integrative biology 20 (2), 65-68, 2016 | 28 | 2016 |
| Circulating pEGFR Is a Candidate Response Biomarker of Cetuximab Therapy in Colorectal CancerpEGFR Is a Response Biomarker of Cetuximab Therapy in CRC T Katsila, M Juliachs, J Gregori, T Macarulla, L Villarreal, A Bardelli, ... Clinical Cancer Research 20 (24), 6346-6356, 2014 | 27 | 2014 |
| Pharmacometabolomics-aided pharmacogenomics in autoimmune disease T Katsila, E Konstantinou, I Lavda, H Malakis, I Papantoni, L Skondra, ... EBioMedicine 5, 40-45, 2016 | 26 | 2016 |
| Individualizing fetal hemoglobin augmenting therapy for β-type hemoglobinopathies patients A Gravia, V Chondrou, A Sgourou, I Papantoni, J Borg, T Katsila, ... Pharmacogenomics 15 (10), 1355-1364, 2014 | 26 | 2014 |
